474 related articles for article (PubMed ID: 26980039)
21. The spectrum of Merkel cell polyomavirus expression in Merkel cell carcinoma, in a variety of cutaneous neoplasms, and in neuroendocrine carcinomas from different anatomical sites.
Ly TY; Walsh NM; Pasternak S
Hum Pathol; 2012 Apr; 43(4):557-66. PubMed ID: 21940035
[TBL] [Abstract][Full Text] [Related]
22. Usefulness of ulceration and hyperkeratosis as clinical predictors of Merkel cell polyomavirus-negative and combined Merkel cell carcinoma: A retrospective study.
Nagase K; Kimura-Kaku H; Inoue T; Shinogi T; Narisawa Y
J Dermatol; 2019 Feb; 46(2):103-109. PubMed ID: 30565285
[TBL] [Abstract][Full Text] [Related]
23. Immunophenotyping of patients with oral squamous cell carcinoma in peripheral blood and associated tumor tissue.
Grimm M; Feyen O; Hofmann H; Teriete P; Biegner T; Munz A; Reinert S
Tumour Biol; 2016 Mar; 37(3):3807-16. PubMed ID: 26474587
[TBL] [Abstract][Full Text] [Related]
24. Merkel cell carcinoma: histopathologic and prognostic features according to the immunohistochemical expression of Merkel cell polyomavirus large T antigen correlated with viral load.
Leroux-Kozal V; Lévêque N; Brodard V; Lesage C; Dudez O; Makeieff M; Kanagaratnam L; Diebold MD
Hum Pathol; 2015 Mar; 46(3):443-53. PubMed ID: 25623078
[TBL] [Abstract][Full Text] [Related]
25. Complete spontaneous regression of primary Merkel cell carcinoma with tumoural infiltration: a systematic review.
Ah-Thiane L; Samimi M; Kervarrec T; Khammari A; Dréno B
Eur J Dermatol; 2021 Jun; 31(3):381-391. PubMed ID: 34080974
[TBL] [Abstract][Full Text] [Related]
26. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
[TBL] [Abstract][Full Text] [Related]
27. T-lymphocyte profiles differ between keratoacanthomas and invasive squamous cell carcinomas of the human skin.
Bauer C; Abdul Pari AA; Umansky V; Utikal J; Boukamp P; Augustin HG; Goerdt S; Géraud C; Felcht M
Cancer Immunol Immunother; 2018 Jul; 67(7):1147-1157. PubMed ID: 29799076
[TBL] [Abstract][Full Text] [Related]
28. Heterogeneity of PD-L1 expression and CD8 tumor-infiltrating lymphocytes among subtypes of cutaneous adnexal carcinomas.
Duverger L; Osio A; Cribier B; Mortier L; De Masson A; Basset-Seguin N; Lebbé C; Battistella M
Cancer Immunol Immunother; 2019 Jun; 68(6):951-960. PubMed ID: 30953116
[TBL] [Abstract][Full Text] [Related]
29. Complete Spontaneous Regression of Merkel Cell Carcinoma After Biopsy: A Case Report and Review of the Literature.
Ahmadi Moghaddam P; Cornejo KM; Hutchinson L; Tomaszewicz K; Dresser K; Deng A; OʼDonnell P
Am J Dermatopathol; 2016 Nov; 38(11):e154-e158. PubMed ID: 27759689
[TBL] [Abstract][Full Text] [Related]
30. Prognostic value of tumor PD-L1 expression combined with CD8
Wang Q; Lou W; Di W; Wu X
Int Immunopharmacol; 2017 Nov; 52():7-14. PubMed ID: 28846888
[TBL] [Abstract][Full Text] [Related]
31. Merkel cell carcinomas infiltrated with CD33
Kervarrec T; Gaboriaud P; Berthon P; Zaragoza J; Schrama D; Houben R; Le Corre Y; Hainaut-Wierzbicka E; Aubin F; Bens G; Domenech J; Guyétant S; Touzé A; Samimi M
J Am Acad Dermatol; 2018 May; 78(5):973-982.e8. PubMed ID: 29273486
[TBL] [Abstract][Full Text] [Related]
32. Detection of the Merkel cell polyomavirus in the neuroendocrine component of combined Merkel cell carcinoma.
Kervarrec T; Samimi M; Gaboriaud P; Gheit T; Beby-Defaux A; Houben R; Schrama D; Fromont G; Tommasino M; Le Corre Y; Hainaut-Wierzbicka E; Aubin F; Bens G; Maillard H; Furudoï A; Michenet P; Touzé A; Guyétant S
Virchows Arch; 2018 May; 472(5):825-837. PubMed ID: 29594354
[TBL] [Abstract][Full Text] [Related]
33. Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA.
Paulson KG; Voillet V; McAfee MS; Hunter DS; Wagener FD; Perdicchio M; Valente WJ; Koelle SJ; Church CD; Vandeven N; Thomas H; Colunga AG; Iyer JG; Yee C; Kulikauskas R; Koelle DM; Pierce RH; Bielas JH; Greenberg PD; Bhatia S; Gottardo R; Nghiem P; Chapuis AG
Nat Commun; 2018 Sep; 9(1):3868. PubMed ID: 30250229
[TBL] [Abstract][Full Text] [Related]
34. Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study.
Romagnoli G; Wiedermann M; Hübner F; Wenners A; Mathiak M; Röcken C; Maass N; Klapper W; Alkatout I
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885584
[TBL] [Abstract][Full Text] [Related]
35. TdT Expression Is a Marker of Better Survival in Merkel Cell Carcinoma, and Expression of B-Cell Markers Is Associated With Merkel Cell Polyomavirus.
Hoang MP; Donizy P; Wu CL; Kopczynski J; Pieniazek M; Miller DM; Ryś J
Am J Clin Pathol; 2020 Jun; 154(1):38-47. PubMed ID: 32134459
[TBL] [Abstract][Full Text] [Related]
36. Immunologic heterogeneity of tumor-infiltrating lymphocyte composition in primary melanoma.
Weiss SA; Han SW; Lui K; Tchack J; Shapiro R; Berman R; Zhong J; Krogsgaard M; Osman I; Darvishian F
Hum Pathol; 2016 Nov; 57():116-125. PubMed ID: 27473267
[TBL] [Abstract][Full Text] [Related]
37. Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival.
Paulson KG; Iyer JG; Tegeder AR; Thibodeau R; Schelter J; Koba S; Schrama D; Simonson WT; Lemos BD; Byrd DR; Koelle DM; Galloway DA; Leonard JH; Madeleine MM; Argenyi ZB; Disis ML; Becker JC; Cleary MA; Nghiem P
J Clin Oncol; 2011 Apr; 29(12):1539-46. PubMed ID: 21422430
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic significance of intratumoral CD8+ tumor-infiltrating lymphocytes in medullary carcinoma.
Igari F; Sato E; Horimoto Y; Takahashi Y; Isomura T; Arakawa A; Kitano S; Saito M
Hum Pathol; 2017 Dec; 70():129-138. PubMed ID: 29122657
[TBL] [Abstract][Full Text] [Related]
39. Usefulness of significant morphologic characteristics in distinguishing between Merkel cell polyomavirus-positive and Merkel cell polyomavirus-negative Merkel cell carcinomas.
Iwasaki T; Matsushita M; Kuwamoto S; Kato M; Murakami I; Higaki-Mori H; Nakajima H; Sano S; Hayashi K
Hum Pathol; 2013 Sep; 44(9):1912-7. PubMed ID: 23664542
[TBL] [Abstract][Full Text] [Related]
40. Quality Is King: Fundamental Insights into Tumor Antigenicity from Virus-Associated Merkel Cell Carcinoma.
Lahman MC; Paulson KG; Nghiem PT; Chapuis AG
J Invest Dermatol; 2021 Aug; 141(8):1897-1905. PubMed ID: 33863500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]